The -590 C/T and 8375 A/G interleukin-4 polymorphisms are not associated with Kawasaki disease in Taiwanese children

Human Immunology

Volumn 69, Issue 1, 2008, Pages 52-57

  Huang, Fu Yuan ^a,b   Chang, Tzu Yang ^a   Chen, Ming Ren ^a,c   Lee, Hung Chang ^a,b   Chiu, Nan Chang ^a   Chi, Hsin ^a,c   Hsu, Chyong Hsin ^a,c   Lin, Shuan Pei ^a,c,d   Liu, Hsin Fu ^a   Chen, Wei Fang ^a   Chu, Chen Chung ^a   Lin, Marie ^a   Lee, Yann Jinn ^a,b  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c NURSING AND MANAGEMENT COLLEGE   (Taiwan)

^d NATIONAL TAIPEI UNIVERSITY OF NURSING AND HEALTH SCIENCES   (Taiwan)

Author keywords

Coronary artery lesion; Interleukin 4; Kawasaki disease; Polymorphism; Taiwanese

Indexed keywords

INTERLEUKIN 4;

ARTICLE; BLOOD SAMPLING; CHILD; CONTROLLED STUDY; DNA EXTRACTION; FEMALE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HEART INJURY; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; TAIWAN;

CHILD; CHILD, PRESCHOOL; CORONARY ARTERY DISEASE; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INFANT; INFANT, NEWBORN; INTERLEUKIN-4; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; POLYMORPHISM, SINGLE NUCLEOTIDE; TAIWAN;

EID: 39549084291     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2007.11.002     Document Type: Article

References (55)

1. Laupland K.B., and Dele Davies H. Epidemiology, etiology, and management of Kawasaki disease: State of the art. Pediatr Cardiol 20 (1999) 177
2. Kawasaki T., Kosaki F., Okawa S., Shigematsu I., and Yanagawa H. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics 54 (1974) 271
3. Taubert K.A., Rowley A.H., and Shulman S.T. Nationwide survey of Kawasaki disease and acute rheumatic fever. J Pediatr 119 (1991) 279
4. Yanagawa H., Nakamura Y., Yashiro M., Fujita Y., Nagai M., Kawasaki T., et al. A nationwide incidence survey of Kawasaki disease in 1985-1986 in Japan. J Infect Dis 158 (1988) 1296
5. Morens D.M., Anderson L.J., and Hurwitz E.S. National surveillance of Kawasaki disease. Pediatrics 65 (1980) 21
6. Leung D.Y., Siegel R.L., Grady S., Krensky A., Meade R., Reinherz E.L., et al. Immunoregulatory abnormalities in mucocutaneous lymph node syndrome. Clin Immunol Immunopathol 23 (1982) 100
7. Leung D.Y., Chu E.T., Wood N., Grady S., Meade R., and Geha R.S. Immunoregulatory T cell abnormalities in mucocutaneous lymph node syndrome. J Immunol 130 (1983) 2002
8. Furukawa S., Matsubara T., Jujoh K., Yone K., Sugawara T., Sasai K., et al. Peripheral blood monocyte/macrophages and serum tumor necrosis factor in Kawasaki disease. Clin Immunol Immunopathol 48 (1988) 247
9. Furukawa S., Matsubara T., Motohashi T., Nakachi S., Sasai K., and Yabuta K. Expression of Fc epsilon R2/CD23 on peripheral blood macrophages/monocytes in Kawasaki disease. Clin Immunol Immunopathol 56 (1990) 280
10. Furukawa F., Ohshio G., and Hamashima Y. Possible polyclonal B cell activation in mucocutaneous lymph node syndrome. Eur J Pediatr 145 (1986) 104
11. Laxer R.M., Schaffer F.M., Myones B.L., Yount W.J., Rowe R.D., Rubin L., et al. Lymphocyte abnormalities and complement activation in Kawasaki disease. Prog Clin Biol Res 250 (1987) 175
12. Ahn S.Y., Jang G.C., Shin J.S., Shin K.M., and Kim D.S. Tumor necrosis factor-alpha levels and promoter polymorphism in patients with Kawasaki disease in Korea. Yonsei Med J 44 (2003) 1021
13. Matsubara T., Furukawa S., and Yabuta K. Serum levels of tumor necrosis factor, interleukin 2 receptor, and interferon-gamma in Kawasaki disease involved coronary-artery lesions. Clin Immunol Immunopathol 56 (1990) 29
14. Maury C.P., Salo E., and Pelkonen P. Circulating interleukin-1 beta in patients with Kawasaki disease. N Engl J Med 319 (1988) 1670
15. Kim D.S. Serum interleukin-6 in Kawasaki disease. Yonsei Med J 33 (1992) 183
16. Hirao J., Hibi S., Andoh T., and Ichimura T. High levels of circulating interleukin-4 and interleukin-10 in Kawasaki disease. Int Arch Allergy Immunol 112 (1997) 152
17. Paul W.E. Interleukin-4: A prototypic immunoregulatory lymphokine. Blood 77 (1991) 1859
18. Rocken M., Racke M., and Shevach E.M. IL-4-induced immune deviation as antigen-specific therapy for inflammatory autoimmune disease. Immunol Today 17 (1996) 225
19. Defrance T., Vanbervliet B., Pene J., and Banchereau J. Human recombinant IL-4 induces activated B lymphocytes to produce IgG and IgM. J Immunol 141 (1988) 2000
20. Rousset F., Garcia E., and Banchereau J. Cytokine-induced proliferation and immunoglobulin production of human B lymphocytes triggered through their CD40 antigen. J Exp Med 173 (1991) 705
21. Nonaka M., Nonaka R., Woolley K., Adelroth E., Miura K., Okhawara Y., et al. Distinct immunohistochemical localization of IL-4 in human inflamed airway tissues. IL-4 is localized to eosinophils in vivo and is released by peripheral blood eosinophils. J Immunol 155 (1995) 3234
22. Galea P., Chartier A., and Lebranchu Y. Increased lymphocyte adhesion to allogeneic endothelial cells by interleukin-4 (IL-4). Transplant Proc 23 (1991) 243
23. Lee Y.W., Kuhn H., Hennig B., Neish A.S., and Toborek M. IL-4-induced oxidative stress upregulates VCAM-1 gene expression in human endothelial cells. J Mol Cell Cardiol 33 (2001) 83
24. Rollins B.J., and Pober J.S. Interleukin-4 induces the synthesis and secretion of MCP-1/JE by human endothelial cells. Am J Pathol 138 (1991) 1315
25. Lee Y.W., Hennig B., and Toborek M. Redox-regulated mechanisms of IL-4-induced MCP-1 expression in human vascular endothelial cells. Am J Physiol Heart Circ Physiol 284 (2003) H185
26. Burns J.C., Shimizu C., Shike H., Newburger J.W., Sundel R.P., Baker A.L., et al. Family-based association analysis implicates IL-4 in susceptibility to Kawasaki disease. Genes Immun 6 (2005) 438
27. Wu S.F., Chang J.S., Wan L., Tsai C.H., and Tsai F.J. Association of IL-1Ra gene polymorphism, but no association of IL-1beta and IL-4 gene polymorphisms, with Kawasaki disease. J Clin Lab Anal 19 (2005) 99
28. Council on Cardiovascular Disease in the Young, Committee on Rheumatic Fever E, and Kawasaki Disease, and American Heart Association. Diagnostic guidelines for Kawasaki disease. Circulation 103 (2001) 335
29. Arjunan K., Daniels S.R., Meyer R.A., Schwartz D.C., Barron H., and Kaplan S. Coronary artery caliber in normal children and patients with Kawasaki disease but without aneurysms: An echocardiographic and angiographic study. J Am Coll Cardiol 8 (1986) 1119
30. Lee H.H., Chao H.T., Ng H.T., and Choo K.B. Direct molecular diagnosis of CYP21 mutations in congenital adrenal hyperplasia. J Med Genet 33 (1996) 371
31. Rosenwasser L.J., Klemm D.J., Dresback J.K., Inamura H., Mascali J.J., Klinnert M., et al. Promoter polymorphisms in the chromosome 5 gene cluster in asthma and atopy. Clin Exp Allergy 25 (1995) 74
32. Choi E.H., Lee H.J., Yoo T., and Chanock S.J. A common haplotype of interleukin-4 gene IL4 is associated with severe respiratory syncytial virus disease in Korean children. J Infect Dis 186 (2002) 1207
33. Bell D.M., Brink E.W., Nitzkin J.L., Hall C.B., Wulff H., Berkowitz I.D., et al. Kawasaki syndrome: Description of two outbreaks in the United States. N Engl J Med 304 (1981) 1568
34. Barrett J.C., Fry B., Maller J., and Daly M.J. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 21 (2005) 263-265
35. Lee Y.J., Chen M.R., Chang W.C., Lo F.S., and Huang F.Y. A freely available statistical program for testing associations. MD Comput 15 (1998) 327
36. Purcell S., Cherny S.S., and Sham P.C. Genetic Power Calculator: Design of linkage and association genetic mapping studies of complex traits. Bioinformatics 19 (2003) 149
37. Sohn M.H., Hur M.W., and Kim D.S. Interleukin 6 gene promoter polymorphism is not associated with Kawasaki disease. Genes Immun 2 (2001) 357
38. Biezeveld M., Geissler J., Merkus M., Kuipers I.M., Ottenkamp J., and Kuijpers T. The involvement of Fc gamma receptor gene polymorphisms in Kawasaki disease. Clin Exp Immunol 147 (2007) 106
39. Khajoee V., Kariyazono H., Ohno T., Ihara K., Mizuno Y., Kusuhara K., et al. Inducible and endothelial constitutive nitric oxide synthase gene polymorphisms in Kawasaki disease. Pediatr Int 45 (2003) 130
40. Tsukahara H., Hiraoka M., Saito M., Nishida K., Kobata R., Tsuchida S., et al. Methylenetetrahydrofolate reductase polymorphism in Kawasaki disease. Pediatr Int 42 (2000) 236
41. Kanai M., Tanabe S., Okada M., Suzuki H., Niki T., Katsuura M., et al. Polymorphisms of heme oxygenase-1 and bilirubin UDP-glucuronosyltransferase genes are not associated with Kawasaki disease susceptibility. Tohoku J Exp Med 200 (2003) 155
42. Leung D.Y. The potential role of cytokine-mediated vascular endothelial activation in the pathogenesis of Kawasaki disease. Acta Paediatr Jpn 33 (1991) 739
43. Leung D.Y., Geha R.S., Newburger J.W., Burns J.C., Fiers W., Lapierre L.A., et al. Two monokines, interleukin 1 and tumor necrosis factor, render cultured vascular endothelial cells susceptible to lysis by antibodies circulating during Kawasaki syndrome. J Exp Med 164 (1986) 1958
44. Leung D.Y., Cotran R.S., Kurt-Jones E., Burns J.C., Newburger J.W., and Pober J.S. Endothelial cell activation and high interleukin-1 secretion in the pathogenesis of acute Kawasaki disease. Lancet 2 (1989) 1298
45. Leung D.Y., Collins T., Lapierre L.A., Geha R.S., and Pober J.S. Immunoglobulin M antibodies present in the acute phase of Kawasaki syndrome lyse cultured vascular endothelial cells stimulated by gamma interferon. J Clin Invest 77 (1986) 1428
46. Marsh D.G., Neely J.D., Breazeale D.R., Ghosh B., Freidhoff L.R., Ehrlich-Kautzky E., et al. Linkage analysis of IL4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations. Science 264 (1994) 1152
47. Xu J., Postma D.S., Howard T.D., Koppelman G.H., Zheng S.L., Stine O.C., et al. Major genes regulating total serum immunoglobulin E levels in families with asthma. Am J Hum Genet 67 (2000) 1163
48. Kabesch M., Tzotcheva I., Carr D., Hofler C., Weiland S.K., Fritzsch C., et al. A complete screening of the IL4 gene: Novel polymorphisms and their association with asthma and IgE in childhood. J Allergy Clin Immunol 112 (2003) 893
49. Furukawa S., Matsubara T., Motohashi T., Sasai K., Nakachi S., Umezawa Y., et al. Increased expression of Fc epsilon R2/CD23 on peripheral blood B lymphocytes and serum IgE levels in Kawasaki disease. Int Arch Allergy Appl Immunol 95 (1991) 7
50. Kusakawa S., and Heiner D.C. Elevated levels of immunoglobulin E in the acute febrile mucocutaneous lymph node syndrome. Pediatr Res 10 (1976) 108
51. Krous H.F., Clausen C.R., and Ray C.G. Elevated immunoglobulin E in infantile polyarteritis nodosa. J Pediatr 84 (1974) 841-845
52. Brosius C.L., Newburger J.W., Burns J.C., Hojnowski-Diaz P., Zierler S., and Leung D.Y. Increased prevalence of atopic dermatitis in Kawasaki disease. Pediatr Infect Dis J 7 (1988) 863
53. Matsuoka S., Tatara K., Nakagawa R., Mori K., and Kuroda Y. Tendency toward atopy in Kawasaki disease. Eur J Pediatr 156 (1997) 30-32
54. Matsubara T., Fujita Y., Sato T., Sasai K., and Furukawa S. The prevalence of allergy in Kawasaki disease. Allergy 53 (1998) 815-816
55. Ioannidis J.P., Ntzani E.E., Trikalinos T.A., and Contopoulos-Ioannidis D.G. Replication validity of genetic association studies. Nat Genet 29 (2001) 306